| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.88 | 0.002 | 0.88 | Diuretic | 0.799 0.003 DBMET01331 0.873 0.002 DBMET01334 0.748 0.003 DBMET01336 0.796 0.003 DBMET01332 0.788 0.003 DBMET01335 0.787 0.003 DBMET01337 0.789 0.003 DBMET01333 | ||
| 0.766 | 0.001 | 0.766 | Electrolyte absorption antagonist | 0.555 0.002 DBMET01331 0.707 0.001 DBMET01334 0.588 0.002 DBMET01336 0.635 0.001 DBMET01332 0.483 0.002 DBMET01335 0.66 0.001 DBMET01337 0.575 0.002 DBMET01333 | ||
| 0.596 | 0.055 | 0.721 | Alpha-glucosidase inhibitor | 0.302 0.159 DBMET01331 0.721 0.03 DBMET01334 0.306 0.157 DBMET01336 0.446 0.097 DBMET01332 0.433 0.101 DBMET01335 0.628 0.048 DBMET01337 0.571 0.06 DBMET01333 | DBMET01334 | |
| 0.542 | 0.003 | 0.759 | Carbonic anhydrase VI inhibitor | 0.334 0.005 DBMET01331 0.759 0.002 DBMET01334 0.3 0.006 DBMET01336 0.41 0.004 DBMET01332 0.464 0.004 DBMET01335 0.441 0.004 DBMET01337 0.555 0.003 DBMET01333 | DBMET01334 | |
| 0.496 | 0.003 | 0.733 | Carbonic anhydrase XIII inhibitor | 0.418 0.004 DBMET01331 0.733 0.002 DBMET01334 0.292 0.006 DBMET01336 0.361 0.004 DBMET01332 0.625 0.003 DBMET01335 0.385 0.004 DBMET01337 0.502 0.003 DBMET01333 | DBMET01334 | |
| 0.391 | 0.005 | 0.447 | M18 aspartyl aminopeptidase inhibitor | 0.441 0.004 DBMET01331 0.406 0.005 DBMET01334 0.33 0.009 DBMET01336 0.409 0.005 DBMET01332 0.447 0.004 DBMET01335 0.361 0.007 DBMET01337 0.422 0.004 DBMET01333 | DBMET01335 | |
| 0.351 | 0.003 | 0.477 | Carbonic anhydrase VII inhibitor | 0.2 0.005 DBMET01331 0.477 0.003 DBMET01334 0.148 0.006 DBMET01336 0.273 0.004 DBMET01332 0.266 0.004 DBMET01335 0.206 0.004 DBMET01337 0.354 0.003 DBMET01333 | DBMET01334 | |
| 0.399 | 0.058 | 0.399 | Thioredoxin glutathione reductase inhibitor | 0.221 0.155 DBMET01331 0.372 0.068 DBMET01334 0.374 0.067 DBMET01336 0.33 0.086 DBMET01332 0.212 0.162 DBMET01335 0.266 0.124 DBMET01337 0.308 0.098 DBMET01333 | ||
| 0.336 | 0.004 | 0.394 | Carbonic anhydrase XII inhibitor | 0.387 0.004 DBMET01331 0.346 0.004 DBMET01334 0.096 0.021 DBMET01336 0.282 0.005 DBMET01332 0.394 0.004 DBMET01335 0.247 0.006 DBMET01337 0.289 0.005 DBMET01333 | DBMET01335 | |
| 0.33 | 0.003 | 0.351 | Carbonic anhydrase VB inhibitor | 0.261 0.004 DBMET01331 0.351 0.003 DBMET01334 0.188 0.005 DBMET01336 0.259 0.004 DBMET01332 0.281 0.004 DBMET01335 0.223 0.004 DBMET01337 0.279 0.004 DBMET01333 | DBMET01334 | |
| 0.33 | 0.004 | 0.449 | Carbonic anhydrase IX inhibitor | 0.449 0.003 DBMET01331 0.317 0.004 DBMET01334 0.1 0.02 DBMET01336 0.269 0.005 DBMET01332 0.431 0.004 DBMET01335 0.233 0.006 DBMET01337 0.258 0.005 DBMET01333 | DBMET01331 | |
| 0.328 | 0.004 | 0.476 | Carbonic anhydrase inhibitor | 0.469 0.003 DBMET01331 0.334 0.004 DBMET01334 0.131 0.019 DBMET01336 0.289 0.005 DBMET01332 0.476 0.003 DBMET01335 0.252 0.006 DBMET01337 0.297 0.005 DBMET01333 | DBMET01335 | |
| 0.322 | 0.009 | 0.392 | Cyclin-dependent kinase 5 inhibitor | 0.392 0.005 DBMET01331 0.281 0.012 DBMET01334 0.173 0.03 DBMET01336 0.362 0.006 DBMET01332 0.351 0.007 DBMET01335 0.246 0.015 DBMET01337 0.329 0.008 DBMET01333 | DBMET01331 | |
| 0.294 | 0.004 | 0.453 | Carbonic anhydrase XIV inhibitor | 0.114 0.008 DBMET01331 0.453 0.003 DBMET01334 0.106 0.009 DBMET01336 0.141 0.005 DBMET01332 0.188 0.004 DBMET01335 0.178 0.004 DBMET01337 0.272 0.004 DBMET01333 | DBMET01334 | |
| 0.291 | 0.004 | 0.327 | Carbonic anhydrase V inhibitor | 0.238 0.005 DBMET01331 0.327 0.003 DBMET01334 0.178 0.009 DBMET01336 0.245 0.005 DBMET01332 0.261 0.004 DBMET01335 0.213 0.006 DBMET01337 0.267 0.004 DBMET01333 | DBMET01334 | |
| 0.276 | 0.004 | 0.428 | Carbonic anhydrase II inhibitor | 0.428 0.003 DBMET01331 0.27 0.004 DBMET01334 0.098 0.019 DBMET01336 0.239 0.005 DBMET01332 0.42 0.003 DBMET01335 0.21 0.005 DBMET01337 0.24 0.005 DBMET01333 | DBMET01331 | |
| 0.282 | 0.011 | 0.316 | Cyclin-dependent kinase 3 inhibitor | 0.316 0.007 DBMET01331 0.271 0.012 DBMET01334 0.24 0.018 DBMET01336 0.294 0.009 DBMET01332 0.3 0.009 DBMET01335 0.247 0.017 DBMET01337 0.284 0.01 DBMET01333 | DBMET01331 | |
| 0.26 | 0.004 | 0.29 | Carbonic anhydrase VA inhibitor | 0.21 0.004 DBMET01331 0.29 0.003 DBMET01334 0.165 0.008 DBMET01336 0.216 0.004 DBMET01332 0.228 0.004 DBMET01335 0.19 0.005 DBMET01337 0.234 0.004 DBMET01333 | DBMET01334 | |
| 0.377 | 0.128 | 0.47 | DNA polymerase beta inhibitor | 0.46 0.098 DBMET01331 0.387 0.125 DBMET01334 0.244 0.196 DBMET01332 0.47 0.095 DBMET01335 0.242 0.197 DBMET01333 | DBMET01335 | |
| 0.281 | 0.032 | 0.385 | Non-steroidal antiinflammatory agent | 0.36 0.018 DBMET01331 0.304 0.027 DBMET01334 0.281 0.032 DBMET01332 0.385 0.015 DBMET01335 0.179 0.088 DBMET01337 0.298 0.028 DBMET01333 | DBMET01335 | |
| 0.34 | 0.092 | 0.34 | Antiobesity | 0.284 0.128 DBMET01334 | ||
| 0.289 | 0.052 | 0.302 | Vasodilator | 0.302 0.047 DBMET01334 0.226 0.085 DBMET01336 0.16 0.143 DBMET01332 0.243 0.073 DBMET01337 0.188 0.115 DBMET01333 | DBMET01334 | |
| 0.341 | 0.104 | 0.464 | 15-Lipoxygenase inhibitor | 0.464 0.049 DBMET01334 0.267 0.151 DBMET01332 0.308 0.126 DBMET01335 0.273 0.148 DBMET01337 0.383 0.082 DBMET01333 | DBMET01334 | |
| 0.203 | 0.008 | 0.263 | Cannabinoid receptor antagonist | 0.263 0.005 DBMET01331 0.099 0.029 DBMET01334 0.149 0.015 DBMET01332 0.135 0.017 DBMET01335 0.073 0.046 DBMET01333 | DBMET01331 | |
| 0.212 | 0.028 | 0.291 | Cyclooxygenase 2 inhibitor | 0.291 0.014 DBMET01331 0.198 0.031 DBMET01334 0.159 0.048 DBMET01336 0.242 0.021 DBMET01332 0.269 0.017 DBMET01335 0.16 0.047 DBMET01337 0.227 0.024 DBMET01333 | DBMET01331 | |
| 0.197 | 0.034 | 0.401 | Alkaline phosphatase inhibitor | 0.322 0.009 DBMET01331 0.242 0.022 DBMET01334 0.308 0.011 DBMET01332 0.401 0.005 DBMET01335 0.116 0.09 DBMET01337 0.366 0.007 DBMET01333 | DBMET01335 | |
| 0.164 | 0.006 | 0.256 | Cannabinoid CB1 receptor antagonist | 0.256 0.004 DBMET01331 0.082 0.025 DBMET01334 0.102 0.016 DBMET01332 0.124 0.01 DBMET01335 0.055 0.052 DBMET01333 | DBMET01331 | |
| 0.192 | 0.045 | 0.283 | Cyclooxygenase inhibitor | 0.283 0.02 DBMET01331 0.191 0.045 DBMET01334 0.138 0.08 DBMET01336 0.225 0.033 DBMET01332 0.271 0.022 DBMET01335 0.143 0.076 DBMET01337 0.22 0.034 DBMET01333 | DBMET01331 | |
| 0.229 | 0.104 | 0.244 | 5 Hydroxytryptamine uptake stimulant | 0.23 0.104 DBMET01331 0.223 0.112 DBMET01334 0.244 0.087 DBMET01332 0.224 0.112 DBMET01335 0.188 0.177 DBMET01337 0.234 0.098 DBMET01333 | DBMET01332 | |
| 0.124 | 0.005 | 0.138 | Carbonic anhydrase IV inhibitor | 0.138 0.004 DBMET01331 0.113 0.005 DBMET01334 0.064 0.017 DBMET01336 0.109 0.006 DBMET01332 0.123 0.005 DBMET01335 0.096 0.008 DBMET01337 0.101 0.007 DBMET01333 | DBMET01331 | |
| 0.108 | 0.005 | 0.108 | Nitric oxide donor | 0.06 0.048 DBMET01331 0.105 0.007 DBMET01334 0.101 0.008 DBMET01336 0.095 0.011 DBMET01332 0.058 0.053 DBMET01335 0.106 0.006 DBMET01337 0.092 0.013 DBMET01333 | ||
| 0.155 | 0.054 | 0.18 | Cyclin-dependent kinase inhibitor | 0.18 0.044 DBMET01331 0.119 0.074 DBMET01334 0.154 0.054 DBMET01332 0.135 0.064 DBMET01335 0.104 0.086 DBMET01337 0.124 0.071 DBMET01333 | DBMET01331 | |
| 0.112 | 0.015 | 0.378 | Carbonic anhydrase I inhibitor | 0.378 0.004 DBMET01331 0.104 0.017 DBMET01334 0.145 0.011 DBMET01332 0.355 0.004 DBMET01335 0.079 0.025 DBMET01337 0.138 0.011 DBMET01333 | DBMET01331 | |
| 0.252 | 0.156 | 0.388 | Beta lactamase inhibitor | 0.388 0.103 DBMET01331 0.21 0.179 DBMET01332 0.241 0.161 DBMET01335 | DBMET01331 | |
| 0.269 | 0.18 | 0.386 | DNA directed DNA polymerase inhibitor | 0.365 0.131 DBMET01331 0.289 0.168 DBMET01334 0.386 0.122 DBMET01335 | DBMET01335 | |
| 0.241 | 0.155 | 0.285 | Toll-Like receptor 7 agonist | 0.241 0.156 DBMET01334 0.285 0.12 DBMET01332 0.285 0.12 DBMET01333 | DBMET01333 | |
| 0.126 | 0.042 | 0.271 | Carbonic anhydrase XV inhibitor | 0.204 0.018 DBMET01331 0.167 0.025 DBMET01334 0.166 0.026 DBMET01332 0.271 0.01 DBMET01335 0.095 0.074 DBMET01337 0.22 0.015 DBMET01333 | DBMET01335 | |
| 0.134 | 0.058 | 0.141 | CC chemokine 6 receptor antagonist | 0.137 0.048 DBMET01331 0.135 0.054 DBMET01334 0.122 0.107 DBMET01336 0.141 0.037 DBMET01332 0.138 0.046 DBMET01335 0.137 0.046 DBMET01337 0.141 0.036 DBMET01333 | DBMET01333 | |
| 0.231 | 0.167 | 0.273 | Toll-Like receptor agonist | 0.231 0.166 DBMET01334 0.272 0.13 DBMET01332 0.273 0.129 DBMET01333 | DBMET01333 | |
| 0.057 | 0.009 | 0.057 | Phenylethanolamine N methyltransferase inhibitor | 0.052 0.013 DBMET01334 0.045 0.02 DBMET01336 0.049 0.015 DBMET01337 | ||
| 0.121 | 0.08 | 0.197 | Cyclooxygenase 1 inhibitor | 0.182 0.042 DBMET01331 0.14 0.063 DBMET01334 0.142 0.061 DBMET01332 0.197 0.036 DBMET01335 0.163 0.05 DBMET01333 | DBMET01335 | |
| 0.103 | 0.081 | 0.117 | CDK3/cyclin E inhibitor | 0.117 0.06 DBMET01331 0.107 0.075 DBMET01332 0.105 0.079 DBMET01335 0.098 0.091 DBMET01333 | DBMET01331 | |
| 0.177 | 0.167 | 0.292 | Lipoxygenase inhibitor | 0.292 0.075 DBMET01334 0.216 0.125 DBMET01335 0.258 0.095 DBMET01333 | DBMET01334 | |
| 0.198 | 0.191 | 0.292 | Sodium/bile acid cotransporter inhibitor | 0.287 0.091 DBMET01334 0.209 0.176 DBMET01332 0.267 0.11 DBMET01335 0.27 0.108 DBMET01337 0.292 0.087 DBMET01333 | DBMET01333 | |
| 0.053 | 0.049 | 0.066 | Cyclin H inhibitor | 0.066 0.032 DBMET01331 0.054 0.048 DBMET01332 0.057 0.043 DBMET01335 | DBMET01331 | |
| 0.13 | 0.126 | 0.15 | Amyloid beta precursor protein antagonist | 0.15 0.101 DBMET01334 0.131 0.125 DBMET01335 0.145 0.107 DBMET01333 | DBMET01334 | |
| 0.144 | 0.144 | 0.51 | Aldehyde oxidase inhibitor | 0.244 0.084 DBMET01331 0.317 0.062 DBMET01334 0.243 0.085 DBMET01332 0.51 0.031 DBMET01335 0.494 0.034 DBMET01333 | DBMET01335 | |
| 0.122 | 0.124 | 0.159 | Pregnane X receptor agonist | 0.159 0.039 DBMET01331 0.13 0.101 DBMET01332 0.151 0.051 DBMET01335 0.123 0.121 DBMET01333 | DBMET01331 | |
| 0.123 | 0.139 | 0.155 | MAP kinase kinase 4 inhibitor | 0.131 0.112 DBMET01331 0.144 0.075 DBMET01334 0.137 0.091 DBMET01332 0.151 0.059 DBMET01335 0.155 0.053 DBMET01333 | DBMET01333 | |
| 0.036 | 0.06 | 0.049 | Purinergic P2X4 antagonist | 0.047 0.029 DBMET01331 0.048 0.028 DBMET01332 0.049 0.026 DBMET01335 0.049 0.025 DBMET01333 | DBMET01333 | |
| 0.04 | 0.064 | 0.061 | CXC chemokine 1 receptor antagonist | 0.047 0.044 DBMET01331 0.051 0.035 DBMET01334 0.053 0.032 DBMET01332 0.057 0.025 DBMET01335 0.061 0.02 DBMET01333 | DBMET01333 | |
| 0.04 | 0.069 | 0.052 | Carbonic anhydrase II stimulant | 0.052 0.036 DBMET01331 | DBMET01331 | |
| 0.073 | 0.11 | 0.184 | Carbonic anhydrase III inhibitor | 0.112 0.051 DBMET01331 0.114 0.048 DBMET01334 0.088 0.078 DBMET01332 0.184 0.019 DBMET01335 0.136 0.034 DBMET01333 | DBMET01335 | |
| 0.152 | 0.189 | 0.246 | Peptidyltransferase inhibitor | 0.181 0.127 DBMET01334 0.179 0.13 DBMET01335 0.246 0.054 DBMET01337 0.191 0.111 DBMET01333 | DBMET01337 | |
| 0.074 | 0.115 | 0.091 | Cyclin-dependent kinase 2 inhibitor | 0.091 0.08 DBMET01331 | DBMET01331 | |
| 0.156 | 0.198 | 0.2 | Thyroid hormone beta antagonist | 0.199 0.154 DBMET01331 0.2 0.153 DBMET01335 | DBMET01335 | |
| 0.07 | 0.115 | 0.089 | ABCA1 expression enhancer | 0.085 0.076 DBMET01331 0.089 0.067 DBMET01335 | DBMET01335 | |
| 0.054 | 0.12 | 0.085 | Cyclin-dependent kinase 1 inhibitor | 0.085 0.079 DBMET01331 | DBMET01331 | |
| 0.056 | 0.126 | 0.069 | Vanilloid 4 agonist | 0.069 0.067 DBMET01331 | DBMET01331 | |
| 0.178 | 0.265 | 0.351 | Analgesic | 0.351 0.108 DBMET01332 0.324 0.124 DBMET01333 | DBMET01332 | |
| 0.136 | 0.226 | 0.193 | Thyroid hormone antagonist | 0.182 0.177 DBMET01331 0.193 0.168 DBMET01335 | DBMET01335 | |
| 0.167 | 0.261 | 0.321 | Transcription factor inhibitor | 0.321 0.144 DBMET01331 0.284 0.164 DBMET01335 | DBMET01331 | |
| 0.106 | 0.2 | 0.216 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.189 0.107 DBMET01331 0.198 0.101 DBMET01332 0.214 0.092 DBMET01335 0.216 0.091 DBMET01333 | DBMET01333 | |
| 0.089 | 0.184 | 0.152 | Dual specificity phosphatase 3 inhibitor | 0.152 0.095 DBMET01335 0.135 0.11 DBMET01333 | DBMET01335 | |
| 0.083 | 0.18 | 0.142 | Mcl-1 antagonist | 0.142 0.098 DBMET01335 0.13 0.112 DBMET01333 | DBMET01335 | |
| 0.089 | 0.278 | 0.193 | Antioxidant | 0.193 0.119 DBMET01334 0.175 0.137 DBMET01337 0.182 0.13 DBMET01333 | DBMET01334 | |
| 0.035 | 0.228 | 0.087 | Urease inhibitor | 0.087 0.082 DBMET01335 | DBMET01335 | |
| 0.085 | 0.282 | 0.273 | Streptokinase A inhibitor | 0.252 0.102 DBMET01331 0.273 0.09 DBMET01335 | DBMET01335 | |
| 0.017 | 0.214 | 0.062 | Prostaglandin-E synthase inhibitor | 0.062 0.06 DBMET01331 | DBMET01331 | |
| 0.078 | 0.301 | 0.132 | CF transmembrane conductance regulator agonist | 0.132 0.112 DBMET01333 | DBMET01333 | |
| 0.128 | 0.403 | 0.303 | Apoptosis agonist | 0.242 0.223 DBMET01336 0.303 0.17 DBMET01337 | DBMET01337 | |
| 0.068 | 0.394 | 0.195 | 12-Lipoxygenase inhibitor | 0.195 0.158 DBMET01335 0.189 0.163 DBMET01333 | DBMET01335 | |
| 0.026 | 0.401 | 0.097 | Beta glucuronidase inhibitor | 0.097 0.075 DBMET01335 | DBMET01335 | |
| 0.051 | 0.549 | 0.237 | Antibacterial | 0.237 0.19 DBMET01337 | DBMET01337 | |
| 0.009 | 0.814 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.095 0.046 DBMET01337 | DBMET01337 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |